These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27285580)

  • 1. G-CSF and Exenatide Might Be Associated with Increased Long-Term Survival of Allogeneic Pancreatic Islet Grafts.
    Zoso A; Serafini P; Lanzoni G; Peixoto E; Messinger S; Mantero A; Padilla-Téllez ND; Baidal DA; Alejandro R; Ricordi C; Inverardi L
    PLoS One; 2016; 11(6):e0157245. PubMed ID: 27285580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept.
    Faradji RN; Tharavanij T; Messinger S; Froud T; Pileggi A; Monroy K; Mineo D; Baidal DA; Cure P; Ponte G; Mendez AJ; Selvaggi G; Ricordi C; Alejandro R
    Transplantation; 2008 Dec; 86(12):1658-65. PubMed ID: 19104401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects.
    Froud T; Faradji RN; Pileggi A; Messinger S; Baidal DA; Ponte GM; Cure PE; Monroy K; Mendez A; Selvaggi G; Ricordi C; Alejandro R
    Transplantation; 2008 Jul; 86(1):36-45. PubMed ID: 18622276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet transplantation for brittle type 1 diabetes: the UIC protocol.
    Gangemi A; Salehi P; Hatipoglu B; Martellotto J; Barbaro B; Kuechle JB; Qi M; Wang Y; Pallan P; Owens C; Bui J; West D; Kaplan B; Benedetti E; Oberholzer J
    Am J Transplant; 2008 Jun; 8(6):1250-61. PubMed ID: 18444920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients.
    Koh A; Imes S; Kin T; Dinyari P; Malcolm A; Toso C; Shapiro AM; Senior P
    Transplantation; 2010 Feb; 89(3):361-5. PubMed ID: 20145529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α.
    Matsumoto S; Takita M; Chaussabel D; Noguchi H; Shimoda M; Sugimoto K; Itoh T; Chujo D; SoRelle J; Onaca N; Naziruddin B; Levy MF
    Cell Transplant; 2011; 20(10):1641-7. PubMed ID: 21396171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
    Froud T; Ricordi C; Baidal DA; Hafiz MM; Ponte G; Cure P; Pileggi A; Poggioli R; Ichii H; Khan A; Ferreira JV; Pugliese A; Esquenazi VV; Kenyon NS; Alejandro R
    Am J Transplant; 2005 Aug; 5(8):2037-46. PubMed ID: 15996257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
    Rother KI; Spain LM; Wesley RA; Digon BJ; Baron A; Chen K; Nelson P; Dosch HM; Palmer JP; Brooks-Worrell B; Ring M; Harlan DM
    Diabetes Care; 2009 Dec; 32(12):2251-7. PubMed ID: 19808924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
    Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
    PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained Islet Allograft Function After Peritransplant Treatment Using Exenatide With and Without Everolimus.
    Bertuzzi F; Marazzi M; De Carlis LG; Rampoldi AG; Bonomo M; Antonioli B; Tosca MC; Galuzzi M; De Gasperi A; Colussi G
    Transplantation; 2016 Nov; 100(11):e117-e118. PubMed ID: 27517727
    [No Abstract]   [Full Text] [Related]  

  • 11. Exendin-4 does not promote Beta-cell proliferation or survival during the early post-islet transplant period in mice.
    Crutchlow MF; Yu M; Bae YS; Deng S; Stoffers DA
    Transplant Proc; 2008 Jun; 40(5):1650-7. PubMed ID: 18589167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exenatide on gastric emptying and graft survival in islet allograft recipients.
    Peixoto EM; Froud T; Gomes LS; Zavala LM; Corrales A; Herrada E; Ricordi C; Alejandro R
    Transplant Proc; 2011 Nov; 43(9):3231-4. PubMed ID: 22099764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
    Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
    Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
    O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
    Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.
    Ghofaili KA; Fung M; Ao Z; Meloche M; Shapiro RJ; Warnock GL; Elahi D; Meneilly GS; Thompson DM
    Transplantation; 2007 Jan; 83(1):24-8. PubMed ID: 17220786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved long-term health-related quality of life after islet transplantation.
    Tharavanij T; Betancourt A; Messinger S; Cure P; Leitao CB; Baidal DA; Froud T; Ricordi C; Alejandro R
    Transplantation; 2008 Nov; 86(9):1161-7. PubMed ID: 19005394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell transplantation.
    Vaithilingam V; Sundaram G; Tuch BE
    Curr Opin Organ Transplant; 2008 Dec; 13(6):633-8. PubMed ID: 19060555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of epitope-based ligation of ICAM-1 on survival and retransplantation of pig islets in nonhuman primates.
    Lee JI; Kim J; Choi YJ; Park HJ; Park HJ; Wi HJ; Yoon S; Shin JS; Park JK; Jung KC; Lee EB; Kang HJ; Hwang ES; Kim SJ; Park CG; Park SH
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29131413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
    Giovannoni L; Muller YD; Lacotte S; Parnaud G; Borot S; Meier RP; Lavallard V; Bédat B; Toso C; Daubeuf B; Elson G; Shang L; Morel P; Kosco-Vilbois M; Bosco D; Berney T
    Transplantation; 2015 Jan; 99(1):29-35. PubMed ID: 25340601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.